A structured 10-month knowledge transfer programme bridging expertise from conventional pharmaceutical manufacturing into the unique science, regulation, and operations of pharmaceutical cannabis production.
This curriculum is designed specifically for production leaders who already hold strong GMP expertise and pharmaceutical manufacturing competencies. It does not repeat what you already know — it targets exclusively the genuine knowledge gaps between conventional pharmaceutical manufacturing and pharmaceutical cannabis.
The programme is delivered during the facility’s construction window — the single best training opportunity available, when there is space to build knowledge, systems, and culture before the demands of live operations begin.
TRANSFERS
TRANSFERS
TRANSFERS
NEW
NEW
NEW
The programme is sequenced to front-load the largest knowledge gaps and build operational readiness in parallel with facility commissioning.
GACP frameworks, pharmaceutical cannabis regulatory landscape, narcotic controls, and dual-authority inspection
readiness.
Cannabis botany, environmental controls, chemovar genetics, and yield forecasting. The plant as your API manufacturing
system.
Harvest handling, CO2 & ethanol extraction, decarboxylation validation, distillation, and pharmaceutical formulation.
CoA literacy, cannabinoid & terpene profiling, contaminant testing, specification setting, and cannabis product stability.
Integrated pest management, biological control agents, primary cannabis pathogens, and facility environmental monitoring
Dual-compliance QMS architecture, SOP development, validation master plan, CAPA, and cannabis
batch release.
Competency frameworks, staff qualification cascades, biological cycle-based production scheduling, and Lean in cannabis.
Each track contains four modules progressing from Foundation through Core, Applied, and Advanced. Tracks can be followed in parallel — click any track to see its modules.
Establishes the compliance foundation before any production begins. Covers the regulatory frameworks governing pharmaceutical cannabis globally — from GACP guidelines through narcotic controls and dual-authority inspection readiness.
Addresses the most fundamental knowledge gap for pharma-experienced professionals: the plant is the API. Covers cannabis biology, environmental controls, genetics, and the science of producing a consistent pharmaceutical-grade botanical starting material.
Covers post-harvest manufacturing operations entirely new to most conventional pharma professionals. From drying validation through to distillation and pharmaceutical formulation — mapping the botanical-to-pharmaceutical transformation process in full.
Translates conventional pharmaceutical QC expertise into the multi-dimensional analytical framework required for cannabis products. Covers cannabinoid and terpene profiling, complex contaminant testing panels, and cannabis-specific stability science.
Covers the biological contamination control discipline that has no direct equivalent in conventional pharmaceutical manufacturing. Builds expertise in the IPM hierarchy, biological control science, primary cannabis pathogens, and facility-level risk management.
Leverages existing pharmaceutical QMS expertise and adapts it to the dual-compliance requirements of cannabis. Covers QMS architecture, SOP development for agricultural teams, validation planning, and the CAPA framework for biological variability.
Addresses operational management disciplines distinct to pharmaceutical cannabis: building competency frameworks for mixed agricultural/pharma teams, managing production around biological cycles, and applying Lean principles in a living system.
© 2026 Flowise
